Achieving hepatitis C elimination in Canada; addressing the needs of the diverse groups at risk

在加拿大实现丙型肝炎消除；

• 批准号: 370911
• 负责人: Greenaway Christina A
• 金额: $ 87.22万
• 依托单位: Lady Davis Institute for Medical Research (Mtl)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2020-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=370911&lang=en
• 关键词: Cascade Of Care; Disease Elimination; Hepatitis C; Risk Groups

Hospitalizations, deaths and costs from hepatitis C are increasing in Canada due to undiagnosed and untreated cases. Hepatitis C virus infections can cause chronic infection of the liver that is silent for 20-30 years before about a fifth of infected peop

在加拿大，由于未确诊和未经治疗的病例，丙型肝炎的住院治疗，死亡和费用正在增加。丙型肝炎病毒感染可引起慢性肝脏感染，在约五分之一的感染者之前，这种感染可持续20-30年。